S84211 |
AP20187 |
源叶(MedMol) | 97% |
- 提示:详情请下载说明书。
- 产品描述: AP20187 (B/B Homodimerizer, HY-13992) 是一种二聚化的化学诱导剂,可激活 FKBP-Casp8
- 靶点: FKBP; Casp8;Others
- 体外研究:
In oligodendrocytes, AP20187 treatment increases the expression of PERK-responsive genes encoding CAATT enhancer binding protein homologous protein (CHOP) and growth arrest and DNA damage 34 (GADD34) in a dose-dependent manner. The activity of PERK signaling in oligodendrocytes can be temporally manipulated by the administration of AP20187
- 体内研究:
AP20187 treatment significantly reduces the number of degenerating axons and increases the density of axons in the demyelinating lesions in the lumbar spinal cord of PLP/Fv2E-PERK mice. AP20187 is also sufficient to activate Fv2E-PERK in oligodendrocytes in the CNS of PLP/Fv2E-PERK mice.
- 细胞实验: Cell lines: Oligodendrocytes Concentrations: 1 nM Incubation Time: 4 h Method: After 3 d of differentiation, the cells are treated with 1 nM AP20187 or vehicle for 4 h and are then fixed with cold 4% paraformaldehyde in PBS. The cells are blocked with PBS containing 10% goat serum and 0.1% Triton X-100 and incubate overnight with the primary antibody diluted in blocking solution. Appropriate fluorochrome-labeled secondary antibodies are used for detection.
- 动物实验: Animal Models: PLP/Fv2E-PERK mice Dosages: 0.5 mg/kg, 2 mg/kg, 5 mg/kg Administration: i.p.
- 参考文献:
1. Darren J Baker, et al. Naturally occurring p16(Ink4a)-positive cells shorten healthy lifespan. Nature . 2016 Feb 11;530(7589):184-9. 2. Wensheng Lin, et al. Oligodendrocyte-specific activation of PERK signaling protects mice against experimental autoimmune encephalomyelitis. J Neurosci . 2013 Apr 3;33(14):5980-91.
- 溶解性: Soluble in DMSO、Ethanol
- 保存条件: -20℃
- 配置溶液浓度参考:
1mg 5mg 10mg 1 mM 0.674 ml 3.372 ml 6.744 ml 5 mM 0.135 ml 0.674 ml 1.349 ml 10 mM 0.067 ml 0.337 ml 0.674 ml 50 mM 0.013 ml 0.067 ml 0.135 ml
- 注意:部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。
输入产品批号:
本计算器可帮助您计算出特定溶液中溶质的质量、溶液浓度和体积之间的关系,公式为:
质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)